Nineteen of 51 (37.3%) of the anti-TIF1γ adult myositis patients had CAM, with seven cases of breast cancer, three ovarian, two lymphoma, and single cases of bowel, hepatic, leukaemia, lung, melanoma, myeloma and oesophageal cancer reported. Here, TRIM33 is linked to melanoma.